Modus Therapeutics receives about SEK 134,000 for warrants exercise

Company said it completed the first exercise period for warrants of series to 2030, receiving about SEK 134,000 and subscribing 335,166 new shares at SEK 0.40 per share, for an exercise rate of 0.88%.